Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
Abstract In the era of immunotherapy, there lacks of a reliable genomic predictor to identify optimal patient populations in combined radiotherapy and immunotherapy (CRI). The purpose of this study is to investigate whether genomic scores defining radiosensitivity are associated with immune response...
Guardado en:
Autores principales: | Yang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, Cheng-Hsiang Lo, Jen-Fu Yang, Chun-Shu Lin, Hsing-Lung Chao, Wen-Yen Huang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4214af13ccb94d3a95aa527a65bc27ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Application of Radiosensitizers in Cancer Radiotherapy
por: Gong L, et al.
Publicado: (2021) -
Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects
por: Yang S, et al.
Publicado: (2021) -
Novel emerging biomarkers to immunotherapy in kidney cancer
por: Yasser Ged, et al.
Publicado: (2021) -
Mutation load estimation model as a predictor of the response to cancer immunotherapy
por: Guan-Yi Lyu, et al.
Publicado: (2018) -
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer
por: Wu M, et al.
Publicado: (2018)